1-4 of 4
suspensions
Close
Sort by
Journal Articles

Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience

Marta Riva, Lara Crucitti, Emanuele Ravano, MD, Michele Nichelatti, PhD, Gianluigi Reda, MD, Cristina Fiamenghi, Roberto Cairoli, Alfredo Molteni, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4375.
https://doi.org/10.1182/blood-2018-99-115283
Published: 2018
Journal Articles

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Gianluigi Reda, MD, Ramona Cassin, Veronica Mattiello, Tatiana Tonella, Diana Giannarelli, PhD, Bruno Fattizzo, MD, Francesco Onida, MD, Ferdinando Maria Massari, Agostino Cortelezzi, Prof
Journal: Blood
Blood (2017) 130 (Supplement 1): 1747.
https://doi.org/10.1182/blood.V130.Suppl_1.1747.1747
Published: 2017
Journal Articles

Two Cases of Dysfibrinogenemia in Childhood

Roman Kotlin, Ondrej Pastva, Jaromir Novak, Jiri Suttnar, Peter Salaj, Jaroslav Cermak, Jan E Dyr
Journal: Blood
Blood (2014) 124 (21): 5066.
https://doi.org/10.1182/blood.V124.21.5066.5066
Published: 2014
Journal Articles

Velcade as Retreatment of Multiple Myeloma Patients Previously Responsive to Velcade.

Maria Teresa Petrucci, MD, Cristiano Gallucci, MD, Vincenzo Federico, Patrizia Del Bianco, PhD, Robert Foa, MD
Journal: Blood
Blood (2006) 108 (11): 5088.
https://doi.org/10.1182/blood.V108.11.5088.5088
Published: 2006